Briana Dunn

Briana Dunn is a Senior Associate at RA Capital Management, LLC, where she has been involved in analyzing competitive landscapes for drugs and medical devices. Her role allows her to integrate various interests she explored during her academic career, particularly through her participation in the Marble Center for Cancer Nanomedicine's Convergence Scholars Program at MIT, which helped her transition from academia to industry.2

Academic Background

Before her current position, Dunn completed her postdoctoral research at the Belcher Lab at MIT from 2016 to 2018. Her research primarily focused on utilizing M13 bacteriophage for various applications in nanomedicine.12 This experience laid a strong foundation for her subsequent career in the biotech and investment sectors.

Career Progression

Dunn started her career at RA Capital Management as an Associate in 2018, where she quickly advanced to the role of Senior Associate by 2021. Her work involves creating detailed analyses that inform investment strategies in the healthcare sector.345

Skills and Interests

Throughout her career, Dunn has developed skills in communication, project management, and medical writing. She has also engaged in outreach initiatives aimed at educating younger audiences about nanotechnology, reflecting her commitment to both scientific advancement and public engagement.2

In summary, Briana Dunn combines a robust academic background with practical experience in investment analysis and healthcare innovation, making her a valuable asset to RA Capital Management.